Cancer Research The Future of Cancer Research: Science and Patient Impact  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 55, 1883-1893, May 1, 1995]
© 1995 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dlugosz, A. A.
Right arrow Articles by Yuspa, S. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dlugosz, A. A.
Right arrow Articles by Yuspa, S. H.

Autocrine Transforming Growth Factor {alpha} Is Dispensible for v-rasHa-induced Epidermal Neoplasia: Potential Involvement of Alternate Epidermal Growth Factor Receptor Ligands1

Andrzej A. Dlugosz2, Christina Cheng, Erin K. Williams, Nadine Darwiche, Peter J. Dempsey, Bruce Mann, Ashley R. Dunn, Robert J. Coffey, Jr. and Stuart H. Yuspa

Laboratory of Cellular Carcinogenesis and Tumor Promotion, Division of Cancer Etiology, National Cancer Institute, Bethesda, Maryland 20892 [A. A. D., C. C., E. K. W., N. D., S. H. Y.]; Departments of Medicine and Cell Biology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232 [P. J. D., R. J. C.]; and Ludwig Institute for Cancer Research, Royal Melbourne Hospital, Victoria 3050, Australia [B. M., A. R. D.]

Autocrine epidermal growth factor receptor activation by transforming growth factor {alpha} (TGF{alpha}) has been implicated in growth stimulation during epithelial neoplasia. Using keratinocytes isolated from mice with genetic defects in TGF{alpha} expression, we tested whether TGF{alpha} is required for transformation by the v-rasHa oncogene. Introduction of v-rasHa into primary epidermal cultures using a retroviral vector stimulated growth of both control (TGF{alpha} +/+, BALB/c) and TGF{alpha}-deficient (TGF{alpha} -/-, wa-1) keratinocytes. Moreover, v-rasHa elicited characteristic changes in marker expression (keratin 1 was suppressed; keratin 8 was induced), previously shown to be associated with epidermal growth factor (EGF) receptor activation, in both TGF{alpha} +/+ and TGF{alpha} -/- keratinocytes. v-rasHa markedly increased secreted (>10-fold) and cell-associated (2–3-fold) TGF{alpha} levels in keratinocytes from TGF{alpha} +/+ and BALB/c mice, but not TGF{alpha} -/- or wa-1 mice. Based on Northern blot analysis, v-rasHa induced striking up-regulation of transcripts encoding the additional EGF family members amphiregulin, heparin-binding EGF-like growth factor, and betacellulin in cultured keratinocytes from all four mouse strains. Interestingly, in addition to the normal 4.5-kilobase TGF{alpha} transcript, wa-1 keratinocytes expressed two additional TGF{alpha} transcripts, 4.7 and 5.2 kilobases long. All three transcripts were up-regulated in response to v-rasHa, as well as exogenous TGF{alpha} or keratinocyte growth factor treatment, and were also detected in RNA isolated from wa-1 brain and skin. In vivo, v-rasHa keratinocytes from control as well as TGF{alpha}-deficient mice produced squamous tumors when grafted onto nude mice, and these lesions expressed high levels of amphiregulin, heparin-binding EGF-like growth factor, and betacellulin mRNA, regardless of their TGF{alpha} status. These findings indicate that TGF{alpha} is not essential for epidermal neoplasia induced by the v-rasHa oncogene and suggest that another EGF family member(s) may contribute to autocrine growth stimulation of ras-transformed keratinocytes.

1 This work was supported in part by a Thomas B. Fitzpatrick-Kao Corporation Research Award (A. A. D.), and by Grant MCICA46413 and by the Veterans Administration (R. J. C.). R. J. C. is a Veterans Administration Clinical Investigator.

2 To whom requests for reprints should be addressed, at LCCTP/NCI, Bldg 37/Rm 3B08, 37 Convent DR MSC 4255, Bethesda, MD 20892-4255.

Received 12/ 1/94. Accepted 2/24/95.




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
M. R. Schneider, S. Werner, R. Paus, and E. Wolf
Beyond Wavy Hairs: The Epidermal Growth Factor Receptor and Its Ligands in Skin Biology and Pathology
Am. J. Pathol., July 1, 2008; 173(1): 14 - 24.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
M. A. Stepp, Y. Liu, S. Pal-Ghosh, R. A. Jurjus, G. Tadvalkar, A. Sekaran, K. LoSicco, L. Jiang, M. Larsen, L. Li, et al.
Reduced migration, altered matrix and enhanced TGFbeta1 signaling are signatures of mouse keratinocytes lacking Sdc1
J. Cell Sci., August 15, 2007; 120(16): 2851 - 2863.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Fujimoto, M. Wislez, J. Zhang, K. Iwanaga, J. Dackor, A. E. Hanna, S. Kalyankrishna, D. D. Cody, R. E. Price, M. Sato, et al.
High Expression of ErbB Family Members and Their Ligands in Lung Adenocarcinomas That Are Sensitive to Inhibition of Epidermal Growth Factor Receptor
Cancer Res., December 15, 2005; 65(24): 11478 - 11485.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
S. Kansra, S. W. Stoll, J. L. Johnson, and J. T. Elder
Autocrine Extracellular Signal-regulated Kinase (ERK) Activation in Normal Human Keratinocytes: Metalloproteinase-mediated Release of Amphiregulin Triggers Signaling from ErbB1 to ERK
Mol. Biol. Cell, September 1, 2004; 15(9): 4299 - 4309.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. D. Billings, M. D. Southall, T. Li, P. W. Cook, L. Baldridge, W. B. Moores, D. F. Spandau, J. G. Foley, and J. B. Travers
Amphiregulin Overexpression Results in Rapidly Growing Keratinocytic Tumors: An In Vivo Xenograft Model of Keratoacanthoma
Am. J. Pathol., December 1, 2003; 163(6): 2451 - 2458.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
X. Liu, J. Lee, M. Cooley, E. Bhogte, S. Hartley, and A. Glick
Smad7 but not Smad6 Cooperates with Oncogenic ras to Cause Malignant Conversion in a Mouse Model for Squamous Cell Carcinoma
Cancer Res., November 15, 2003; 63(22): 7760 - 7768.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. M. Grana, C. I. Sartor, and A. D. Cox
Epidermal Growth Factor Receptor Autocrine Signaling in RIE-1 Cells Transformed by the Ras Oncogene Enhances Radiation Resistance
Cancer Res., November 15, 2003; 63(22): 7807 - 7814.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
B. D. Abbott, A. R. Buckalew, M. J. DeVito, D. Ross, P. L. Bryant, and J. E. Schmid
EGF and TGF-{alpha} Expression Influence the Developmental Toxicity of TCDD: Dose Response and AhR Phenotype in EGF, TGF-{alpha}, and EGF + TGF-{alpha} Knockout Mice
Toxicol. Sci., January 1, 2003; 71(1): 84 - 95.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. L. Casanova, F. Larcher, B. Casanova, R. Murillas, M. J. Fernandez-Acenero, C. Villanueva, J. Martinez-Palacio, A. Ullrich, C. J. Conti, and J. L. Jorcano
A Critical Role for ras-mediated, Epidermal Growth Factor Receptor-dependent Angiogenesis in Mouse Skin Carcinogenesis
Cancer Res., June 1, 2002; 62(12): 3402 - 3407.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
P. L. Bryant, J. E. Schmid, S. E. Fenton, A. R. Buckalew, and B. D. Abbott
Teratogenicity of 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) in Mice Lacking the Expression of EGF and/or TGF-{{alpha}}
Toxicol. Sci., July 1, 2001; 62(1): 103 - 114.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. J. Reddig, N. E. Dreckschimdt, H. Ahrens, R. Simsiman, C.-P. Tseng, J. Zou, T. D. Oberley, and A. K. Verma
Transgenic Mice Overexpressing Protein Kinase C{{delta}} in the Epidermis Are Resistant to Skin Tumor Promotion by 12-O-Tetradecanoylphorbol-13-acetate
Cancer Res., November 1, 1999; 59(22): 5710 - 5718.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
L. A. Opanashuk, R. J. Mark, J. Porter, D. Damm, M. P. Mattson, and K. B. Seroogy
Heparin-Binding Epidermal Growth Factor-Like Growth Factor in Hippocampus: Modulation of Expression by Seizures and Anti-Excitotoxic Action
J. Neurosci., January 1, 1999; 19(1): 133 - 146.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. M. Gangarosa, N. Sizemore, R. Graves-Deal, S. M. Oldham, C. J. Der, and R. J. Coffey
A Raf-independent Epidermal Growth Factor Receptor Autocrine Loop Is Necessary for Ras Transformation of Rat Intestinal Epithelial Cells
J. Biol. Chem., July 25, 1997; 272(30): 18926 - 18931.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. F. Denning, A. A. Dlugosz, D. W. Threadgill, T. Magnuson, and S. H. Yuspa
Activation of the Epidermal Growth Factor Receptor Signal Transduction Pathway Stimulates Tyrosine Phosphorylation of Protein Kinase C [IMAGE]
J. Biol. Chem., March 8, 1996; 271(10): 5325 - 5331.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1995 by the American Association for Cancer Research.